Crocs (Nasdaq: CROX ) is expected to report Q4 earnings on Feb. 20. Here's what Wall Street wants to see:
The 10-second takeaway
Comparing the upcoming quarter to the prior-year quarter, average analyst estimates predict Crocs's revenues will grow 8.9% and EPS will wither -100.0%.
The average estimate for revenue is $221.8 million. On the bottom line, the average EPS estimate is $0.00.
Last quarter, Crocs booked revenue of $295.6 million. GAAP reported sales were 7.5% higher than the prior-year quarter's $274.9 million.
Source: S&P Capital IQ. Quarterly periods. Dollar amounts in millions. Non-GAAP figures may vary to maintain comparability with estimates.
Last quarter, EPS came in at $0.49. GAAP EPS of $0.49 for Q3 were 48% higher than the prior-year quarter's $0.33 per share.
Source: S&P Capital IQ. Quarterly periods. Non-GAAP figures may vary to maintain comparability with estimates.
For the preceding quarter, gross margin was 54.4%, 90 basis points better than the prior-year quarter. Operating margin was 13.5%, 60 basis points better than the prior-year quarter. Net margin was 15.3%, 430 basis points better than the prior-year quarter.
The full year's average estimate for revenue is $1.12 billion. The average EPS estimate is $1.41.
The stock has a two-star rating (out of five) at Motley Fool CAPS, with 1,686 members out of 2,356 rating the stock outperform, and 670 members rating it underperform. Among 486 CAPS All-Star picks (recommendations by the highest-ranked CAPS members), 331 give Crocs a green thumbs-up, and 155 give it a red thumbs-down.
Of Wall Street recommendations tracked by S&P Capital IQ, the average opinion on Crocs is outperform, with an average price target of $23.71.
Selling to fickle consumers is a tough business for Crocs or anyone else in the space. But some companies are better equipped to face the future than others. In a new report, we'll give you the rundown on three companies that are setting themselves up to dominate retail. Click here for instant access to this free report.
- Add Crocs to My Watchlist.